文献速递甲状腺疾病

甲状腺功能亢进症治疗可降低系统性氧化应激:RNA和DNA损伤标志物证据

Treatment of Hyperthyroidism Reduces Systemic Oxidative Stress, as Measured by Markers of RNA and DNA Damage.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究在51例甲亢患者中测定尿8-oxoGuo和8-oxodG排泄水平,比较治疗前与甲功稳定正常至少12个月后的变化。结果显示基线氧化应激标志物与血浆甲状腺素正相关,且Graves病高于毒性结节性甲状腺肿;恢复甲功正常后两种标志物均显著下降,提示甲亢治疗可降低系统性氧化应激负荷。

要点

  • 甲亢患者基线尿8-oxoGuo和8-oxodG与血浆甲状腺素正相关。
  • Graves病患者的氧化应激标志物水平显著高于毒性结节性甲状腺肿患者。
  • 恢复甲功正常后氧化应激标志物显著下降,提示治疗可降低氧化应激负荷。

核心结论

  • 甲亢患者恢复甲功正常后系统性氧化应激负荷显著降低10%至25%。
  • 该发现可能有助于解释观察性研究中甲亢相关较高发病率和死亡率。

研究设计与样本

  • 研究纳入51例甲亢患者,其中毒性结节性甲状腺肿30例,Graves病21例。
  • 在治疗前或治疗开始后不久及甲功稳定正常至少12个月时测定尿8-oxoGuo和8-oxodG排泄。

主要发现

  • 校正年龄后,基线尿氧化应激标志物与血浆甲状腺素正相关(8-oxoGuo P=0.002;8-oxodG P=0.021)。
  • 基线时Graves病患者的两种氧化应激标志物均显著高于毒性结节性甲状腺肿患者(两者P=0.001)。
  • 毒性结节性甲状腺肿患者8-oxoGuo从几何均值2.11 nmol/mmol肌酐(95%CI 1.85-2.39)降至1.91 nmol/mmol(95%CI 1.67-2.19;P=0.001)。
  • 毒性结节性甲状腺肿患者8-oxodG从1.65 nmol/mmol(95%CI 1.41-1.93)降至1.48 nmol/mmol(95%CI 1.27-1.74;P=0.026)。
  • Graves病患者8-oxoGuo从2.25 nmol/mmol(95%CI 1.95-2.59)降至1.79 nmol/mmol(95%CI 1.63-1.97;P=0.0003)。

关键数值与推荐

  • Graves病患者8-oxodG从2.02 nmol/mmol(95%CI 1.73-2.38)降至1.54 nmol/mmol(95%CI 1.31-1.81;P=0.001)。
  • 甲功正常状态下两组间氧化应激标志物无差异。

临床怎么用

  • 甲亢治疗恢复甲功正常可显著降低系统性氧化应激负荷,支持积极治疗甲亢以降低氧化应激相关风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whole-body oxidative stress can be estimated by the urine excretion of oxidized guanosine species, 8-oxo-7,8-dihydroguanosine (8-oxoGuo) and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), derived from RNA and DNA, respectively. These oxidative stress markers are not well explored in thyroid disorders. OBJECTIVE: We aimed to determine whether treatment of hyperthyroid patients affects the levels of these oxidative stress markers. METHODS: Urinary excretion of 8-oxoGuo and 8-oxodG was measured in 51 hyperthyroid patients (toxic nodular goiter [TNG], n = 30; Graves disease [GD], n = 21) before or shortly after initiation of therapy and when stable euthyroidism had been achieved for at least 12 months. RESULTS: Adjusting for age, the baseline urinary excretion of oxidative stress markers correlated positively with plasma thyroxine (8-oxoGuo, P = 0.002; 8-oxodG, P = 0.021) and was significantly higher in GD than in TNG patients (P = 0.001 for both oxidative stress markers). Restoration of euthyroidism significantly affected the excretion of the oxidative stress markers. In TNG, 8-oxoGuo decreased from geometric mean 2.11 nmol/mmol creatinine (95% CI, 1.85-2.39) to 1.91 nmol/mmol (95% CI, 1.67-2.19; P = 0.001), while 8-oxodG decreased from 1.65 nmol/mmol (95% CI, 1.41-1.93) to 1.48 nmol/mmol (95% CI, 1.27-1.74; P = 0.026). In GD, 8-oxoGuo decreased from 2.25 nmol/mmol (95% CI, 1.95-2.59) to 1.79 nmol/mmol (95% CI, 1.63-1.97; P = 0.0003), while 8-oxodG decreased from 2.02 nmol/mmol (95% CI, 1.73-2.38) to 1.54 nmol/mmol (95% CI, 1.31-1.81; P = 0.001). In the euthyroid state, there were no differences between groups. CONCLUSION: Restoration of euthyroidism in patients with hyperthyroidism significantly decreased the systemic oxidative stress load by 10% to 25%. Our findings may help to explain the higher morbidity and mortality linked to hyperthyroid diseases, as shown in observational studies.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Larsen CB, Riis KR, Winther KH, et al. Treatment of Hyperthyroidism Reduces Systemic Oxidative Stress, as Measured by Markers of RNA and DNA Damage. J Clin Endocrinol Metab. 2021. PMID: 33901280. doi:10.1210/clinem/dgab273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。